Diaplus Clinic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-05-2024
- Paid Up Capital ₹ 0.10 M
as on 23-05-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -100.00%
(FY 2017)
- Profit 100.00%
(FY 2017)
- Ebitda 100.00%
(FY 2017)
- Net Worth
- Total Assets %
(FY 2017)
About Diaplus Clinic
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manjunath Ankal, Ravikiran Muthuswamy, Abhyudaya Verma, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85100KA2015PTC080293
- Company No.
080293
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 2015
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Diaplus Clinic?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Kota  | Director | 12-May-2015 | Current |
| Manjunath Ankal | Director | 12-May-2015 | Current |
| Ravikiran Muthuswamy | Director | 12-May-2015 | Current |
| Abhyudaya Verma | Director | 12-May-2015 | Current |
| Vivek Prakash | Director | 12-May-2015 | Current |
| Voleti Srinagesh | Director | 12-May-2015 | Current |
Financial Performance and Corporate Structure Insights of Diaplus Clinic.
Diaplus Clinic Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 100% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diaplus Clinic?
In 2017, Diaplus Clinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kalaburagi Scanning And Diagnostic Cente R Llp
Active
8 years 11 months Manjunath Ankal is a mutual person
Diathy Clinic & Hormone Research Institu Te Llp
Active 10 years 1 month Praveen Ramachandra is a mutual person
Future Medical Placement Consultancy Llp
Active 9 years 6 months Praveen Ramachandra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diaplus Clinic?
Unlock and access historical data on people associated with Diaplus Clinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diaplus Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diaplus Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
